RxDoctor Payments Data

Norvin Ona, DO

Family Medicine · Lawrenceville, GANPI 1881765030

Payments from drug & device makers

$29,968in general payments, 2019–2025

Across 1,603 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • Novo Nordisk$4K
  • Amgen$3K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Paratek Pharmaceuticals, Inc.$1K
  • plus $15K from 53 others

What the payments were for

  • Food & beverage$29,75199%
  • Education$2181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca142$3,664
Novo Nordisk175$3,544
Amgen(2 entities)123$2,880
AbbVie(2 entities)165$2,237
Lilly USA, LLC87$1,455
Paratek Pharmaceuticals, Inc.66$1,308
Amarin Pharma, Inc.75$994
Sanofi-aventis U.S. LLC58$944
GSK38$876
Abbott35$790
Pfizer51$768
Astellas Pharma US Inc28$748
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC52$677
Teva Pharmaceuticals USA, Inc.52$613
Bausch Health US, LLC29$581
Takeda Pharmaceuticals U.S.A., Inc.30$547
Corcept Therapeutics28$545
Johnson & Johnson10$471
Corium, LLC17$428
Tris Pharma Inc23$412
Eisai Inc.21$376
Supernus Pharmaceuticals, Inc.13$370
Arbor Pharmaceuticals, Inc.25$319
Biohaven Pharmaceutical Holding Company Ltd.20$316
Upsher-smith Laboratories LLC22$315
Biohaven Pharmaceuticals, Inc.12$309
Kowa Pharmaceuticals America, Inc.14$304
Boehringer Ingelheim20$301
Noven Therapeutics, LLC15$295
Idorsia Pharmaceuticals US Inc15$209
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$209
Daiichi Sankyo Inc.7$208
Merck13$182
Exact Sciences9$163
Axsome Therapeutics, Inc.3$161
Novartis9$146
Aytu Biopharma, Inc.15$129
Currax Pharmaceuticals LLC8$126
Neos Therapeutics, LP7$119
Vivus LLC10$100
Adlon Therapeutics L.p.7$97
Dexcom, Inc.4$79
Esperion Therapeutics, Inc.4$75
Azurity Pharmaceuticals, Inc.4$64
Jazz Pharmaceuticals Inc.3$55
Vanda Pharmaceuticals Inc.3$51
Inspire Medical Systems, Inc.1$48
Impel Pharmaceuticals Inc.3$48
Avanir Pharmaceuticals, Inc.2$43
Nestle Healthcare Nutrition Inc.2$41
Phathom Pharmaceuticals, Inc.2$37
Ironshore Pharmaceuticals Inc.2$37
Biogen1$30
Nalpropion Pharmaceuticals LLC2$30
Ironwood Pharmaceuticals, Inc2$28
Genentech USA, Inc.2$26
Hikma Pharmaceuticals USA1$15
Assertio Therapeutics, Inc.1$13
Sanofi Pasteur Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,968 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$66,168
Medicare patients
217
Services billed
1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$51,767
MounjaroTirzepatide44$50,375
JardianceEmpagliflozin26$33,198
FarxigaDapagliflozin Propanediol23$27,328
RybelsusSemaglutide13$27,273
ProliaDenosumab14$23,539
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$22,388
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$20,781
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog19$15,690
VascepaIcosapent Ethyl16$9,649
Colesevelam Hcl12$5,811
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine31$2,813
SynthroidLevothyroxine Sodium22$2,577
Fenofibrate43$2,407
Rosuvastatin Calcium163$2,284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$3,544$79,04041 claims
Lilly USA, LLCMounjaro$1,455$50,37544 claims
AstraZenecaFarxiga, Breztri Aerosphere$3,664$48,10942 claims
Boehringer IngelheimJardiance$301$33,19826 claims
AmgenProlia$2,880$23,53914 claims
GSKTrelegy Ellipta$876$22,38815 claims
AbbVieSynthroid$2,237$2,57722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Lawrenceville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →